People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Click Diagnostics, Inc. | — | Medical Devices | Series D+ | $235.0M | $2.0B | 2022 |
Mark Ibison at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Ibison on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ajit Singh | 1 | 5 |
| Thomas M. Prescott | 1 | 4 |
| Shlomo Melmed | 1 | 3 |
| STEVEN ROSSTON | 1 | 2 |
| Terri Bresenham | 1 | 1 |
| Eric E. Moessinger | 1 | 1 |
| John Kuo | 1 | 1 |
| Amit M. Shah | 1 | 1 |
| Gregory Loney | 1 | 1 |
| David Engman | 1 | 1 |
| JEROME BEHAR | 1 | 1 |
| ADAM DE LA ZERDA | 1 | 1 |
| Scott E. Mendel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.